Phinomics is a precision-medicine platform company, focused on exploiting unique circular-DNA targets for precision care and identification of new therapeutics. Our discovery is grounded in reproducible science, novel technologies, proprietary workflows, and informatics/AI. Our platform enables rigorous identification of novel pathology-specific circular-DNAs and clinical validation of the previously-hidden targets to address unmet needs with unprecedented resolution.
